Regeneron Pharmaceuticals to buy bankrupt 23andMe in $256M deal Genetic testing company 23andMe filed for Chapter 11 bankruptcy protection in March. Regeneron Pharmaceuticals announced it would buy "substantially all" of 23andMe's assets. Orignial Source: https://www.foxbusiness.com/markets/regeneron-pharmaceuticals-purchase-23andme-256m-deal Previous article: Hawaiian Airlines days into new policy that could cause travelers to lose out on money Prev Next article: White House economic director predicts 'liftoff' once trade deals and tax cuts take shape Next